Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the overall survival (OS) distributions of RP101 and gemcitabine to placebo and gemcitabine in subjects with unresectable, locally advanced or metastatic pancreatic adenocarcinoma.
Critère d'inclusion
- Metastatic Pancreatic Cancer